Immunology Infection Diseases and Tearphy


Being a Managing Editor to Journal of Clinical Immunology and Infection Diseases, I would like to take this opportunity to express my heartfelt thanks to all the authors and professionals for your support to the Journal. Your involvement and contributions towards our journal may be a nice support for us.

Journal of Clinical Immunology and Infection Diseases is a new research Innovation in the various infectious diseases and spread the latest progressions in infectious disease prevention and recovery. Articles on new technology advancement in the field of IMMUNOLOGY, current practices in immune therapy, infection Disease Management, Stem cell Research on diseases.

 Preventing the development of active Tuberculosis (TB) among people living with human immune deficiency virus (PLHIV) can prevent millions of people from being infected in the community and in healthcare services. Increasing knowledge of PLHIV about IPT and uptake of IPT is one of the key interventions recommended by WHO to reduce the burden of TB on PLHIV, while low knowledge level about IPT among PLHIV remain as a major practical barrier for provision of IPT. The main aim of this study was to assess knowledge and associated factor among PLHIV regarding IPT.

The Journal aims to publish the most reliable and complete source of information on the discoveries and current developments in the form of research articles, review articles, case reports and short communication.

For submission of your valuable research work online.

With kind regards,

Andrea Jews

Editorial Manager.                                                           


Journal of Clinical Immunology & Infection Diseases

Tel. No. +3225889658